Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH5 | P11766 | 10/20 | 0.64 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.60 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.60 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.55 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.53 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9812373 | 0.95 | ADH5 (0.66) | ADH5CYP19A1CYP11B1CYP11B2CYP3A4 | |
| SCHEMBL62049 | 0.82 | ADH5 (0.90) | ADH5CYP3A4BAZ2BCYP4Z1TBXAS1 | |
| Hydrochloric Acid SCHEMBL6152702 | 0.81 | ADH5 (0.87) | ADH5CYP3A4BAZ2BCYP4Z1TBXAS1 | |
| SCHEMBL27893085 | 0.81 | ADH5 (0.87) | ADH5CYP3A4BAZ2BCYP4Z1TBXAS1 | |
| SCHEMBL29488338 | 0.80 | IDO1 (0.61) | ADH5CYP3A4BAZ2BCYP4Z1 | |
| SCHEMBL939912 | 0.80 | IDO1 (0.61) | ADH5CYP3A4BAZ2BCYP4Z1 | |
| SCHEMBL17630068 | 0.78 | ADH5 (1.00) | ADH5CYP3A4BAZ2BCYP4Z1HTT | |
| SCHEMBL15021420 | 0.77 | CYP19A1 (0.66) | ADH5CYP19A1CYP11B1CYP11B2MAOA | |
| Trifluoroacetic Acid SCHEMBL4413259 | 0.76 | CYP11B1 (0.73) | ADH5CYP19A1CYP11B1CYP11B2CYP3A4 | |
| Trifluoroacetic Acid SCHEMBL2072297 | 0.76 | CYP11B1 (0.73) | ADH5CYP19A1CYP11B1CYP11B2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107971655-B | High-heat-resistance organic solder flux and application thereof | 永星化工(上海)有限公司 | 2019-12-27 | — | — | CN | claimed |
| EP-0433427-A1 | COMBINED USE OF N-IMIDAZOLYL DERIVATIVES OF BICYCLIC COMPOUNDS AND CYCLOSPORINE IN THERAPY | FARMITALIA CARLO ERBA S.r.l. (IT) | 1991-06-26 | — | — | EP | claimed |
| WO-1991000102-A1 | COMBINED USE OF N-IMIDAZOLYL DERIVATIVES OF BICYCLIC COMPOUNDS AND CYCLOSPORINE IN THERAPY | FARMITALIA CARLO ERBA S.R.L. (IT) | 1991-01-10 | — | — | WO | claimed |
| CN-107971655-B | High-heat-resistance organic solder flux and application thereof | 永星化工(上海)有限公司 | 2019-12-27 | — | — | CN | disclosed |
| EP-0433427-A1 | COMBINED USE OF N-IMIDAZOLYL DERIVATIVES OF BICYCLIC COMPOUNDS AND CYCLOSPORINE IN THERAPY | FARMITALIA CARLO ERBA S.r.l. (IT) | 1991-06-26 | — | — | EP | disclosed |
| WO-1991000102-A1 | COMBINED USE OF N-IMIDAZOLYL DERIVATIVES OF BICYCLIC COMPOUNDS AND CYCLOSPORINE IN THERAPY | FARMITALIA CARLO ERBA S.R.L. (IT) | 1991-01-10 | — | — | WO | disclosed |
| US-4882347-A | NEPHROSIS | FARMITALIA CARLO ERBA, S.R.L. (IT) | 1989-11-21 | — | — | US | disclosed |